Your browser doesn't support javascript.
SARS-CoV-2 Transmissibility Within Day Care Centers-Study Protocol of a Prospective Analysis of Outbreaks in Germany.
Schienkiewitz, Anja; Jordan, Susanne; Hornbacher, Anselm; Perlitz, Hanna; Zeisler, Marie-Luise; Sandoni, Anna; Kubisch, Ulrike; Wess, Barbara; Kuttig, Tim; Schaffrath-Rosario, Angelika; Damerow, Stefan; Rattay, Petra; Varnaccia, Gianni; Loer, Anne-Kathrin M; Wormsbächer, Jan; Cohrdes, Carolin; Wetzstein, Matthias; Albrecht, Stefan; Hey, Isabell; Michel, Janine; Schrick, Livia; Gößwald, Antje; Allen, Jennifer; Schlaud, Martin; Busch, Markus A; Butschalowsky, Hans; Wernitz, Jörg; Otte Im Kampe, Eveline; Buchholz, Udo; Haas, Walter; Schaade, Lars; Wieler, Lothar H; Ziese, Thomas; Lampert, Thomas; Loss, Julika.
  • Schienkiewitz A; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Jordan S; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Hornbacher A; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Perlitz H; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Zeisler ML; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Sandoni A; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Kubisch U; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Wess B; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Kuttig T; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Schaffrath-Rosario A; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Damerow S; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Rattay P; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Varnaccia G; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Loer AM; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Wormsbächer J; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Cohrdes C; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Wetzstein M; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Albrecht S; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Hey I; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Michel J; Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany.
  • Schrick L; Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany.
  • Gößwald A; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Allen J; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Schlaud M; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Busch MA; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Butschalowsky H; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Wernitz J; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Otte Im Kampe E; Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
  • Buchholz U; Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
  • Haas W; Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
  • Schaade L; Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany.
  • Wieler LH; Leadership Robert Koch Institute, Robert Koch Institute, Berlin, Germany.
  • Ziese T; Department of Methodology and Research Infrastructure, Robert Koch Institute, Berlin, Germany.
  • Lampert T; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Loss J; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
Front Public Health ; 9: 773850, 2021.
Article in English | MEDLINE | ID: covidwho-1607729
ABSTRACT

Introduction:

Until today, the role of children in the transmission dynamics of SARS-CoV-2 and the development of the COVID-19 pandemic seems to be dynamic and is not finally resolved. The primary aim of this study is to investigate the transmission dynamics of SARS-CoV-2 in child day care centers and connected households as well as transmission-related indicators and clinical symptoms among children and adults. Methods and

Analysis:

COALA ("Corona outbreak-related examinations in day care centers") is a day care center- and household-based study with a case-ascertained study design. Based on day care centers with at least one reported case of SARS-CoV-2, we include one- to six-year-old children and staff of the affected group in the day care center as well as their respective households. We visit each child's and adult's household. During the home visit we take from each household member a combined mouth and nose swab as well as a saliva sample for analysis of SARS-CoV-2-RNA by real-time reverse transcription polymerase chain reaction (real-time RT-PCR) and a capillary blood sample for a retrospective assessment of an earlier SARS-CoV-2 infection. Furthermore, information on health status, socio-demographics and COVID-19 protective measures are collected via a short telephone interview in the subsequent days. In the following 12 days, household members (or parents for their children) self-collect the same respiratory samples as described above every 3 days and a stool sample for children once. COVID-19 symptoms are documented daily in a symptom diary. Approximately 35 days after testing the index case, every participant who tested positive for SARS-CoV-2 during the study is re-visited at home for another capillary blood sample and a standardized interview. The analysis includes secondary attack rates, by age of primary case, both in the day care center and in households, as well as viral shedding dynamics, including the beginning of shedding relative to symptom onset and viral clearance.

Discussion:

The results contribute to a better understanding of the epidemiological and virological transmission-related indicators of SARS-CoV-2 among young children, as compared to adults and the interplay between day care and households.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Limits: Adult / Child / Child, preschool / Humans / Infant Country/Region as subject: Europa Language: English Journal: Front Public Health Year: 2021 Document Type: Article Affiliation country: Fpubh.2021.773850

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Limits: Adult / Child / Child, preschool / Humans / Infant Country/Region as subject: Europa Language: English Journal: Front Public Health Year: 2021 Document Type: Article Affiliation country: Fpubh.2021.773850